KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biogen (BIIB) Net Income - Minority (2016 - 2023)

Biogen has reported Net Income - Minority over the past 15 years, most recently at $4.1 million for Q3 2023.

  • Quarterly results put Net Income - Minority at $4.1 million for Q3 2023, down 52.87% from a year ago — trailing twelve months through Sep 2023 was $4.1 million (down 52.87% YoY), and the annual figure for FY2022 was $9.5 million, up 114.96%.
  • Net Income - Minority for Q3 2023 was $4.1 million at Biogen, down from $6.4 million in the prior quarter.
  • Over the last five years, Net Income - Minority for BIIB hit a ceiling of $21.6 million in Q1 2022 and a floor of -$462.9 million in Q2 2021.
  • Median Net Income - Minority over the past 5 years was $8.7 million (2022), compared with a mean of -$42.8 million.
  • Biggest five-year swings in Net Income - Minority: soared 375.61% in 2020 and later tumbled 3327.14% in 2021.
  • Biogen's Net Income - Minority stood at $4.1 million in 2019, then surged by 246.34% to $14.2 million in 2020, then crashed by 547.18% to -$63.5 million in 2021, then skyrocketed by 114.96% to $9.5 million in 2022, then tumbled by 56.84% to $4.1 million in 2023.
  • The last three reported values for Net Income - Minority were $4.1 million (Q3 2023), $6.4 million (Q2 2023), and $9.6 million (Q1 2023) per Business Quant data.